{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:01:14Z","timestamp":1790402474630,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Laboratory of Pneumoconiosis of the National Health Commission","award":["NHC202308"],"award-info":[{"award-number":["NHC202308"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Silicosis, a progressive fibrotic lung disease caused by silica dust inhalation, is a significant occupational health concern, particularly among artificial quartz stone workers. Tetrandrine, a bisbenzylisoquinoline alkaloid, is the only plant-derived drug approved for the treatment of silicosis in China. The present study aimed to evaluate the efficacy of tetrandrine in slowing the progression of artificial stone-associated silicosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this retrospective cohort study, patients were divided into an observation group (<jats:italic>n<\/jats:italic>\u2009=\u200953), which received tetrandrine (60\u00a0mg, 3 times daily for 6 consecutive days, followed by a 1-day break, with each cycle lasting 3 months), and a control group (<jats:italic>n<\/jats:italic>\u2009=\u200926), which received only symptomatic treatment. High-resolution computed tomography (HRCT) and pulmonary function tests (PFTs) were performed at baseline and after 12 months of treatment. Progression, stability, or improvement in HRCT findings and changes in PFT parameters were analyzed. Continuous variables and categorical variables were analyzed using the <jats:italic>t<\/jats:italic>-test and chi-square test, respectively, for statistical comparisons.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>After 12 months, 49.1% of patients in the observation group exhibited improvement in HRCT findings, compared to none in the control group, in which 84.6% of individuals exhibited progression. PFT findings improved in the observation group, whereas they significantly declined in the control group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Patients treated with tetrandrine for more than 6 months experienced greater improvements in HRCT findings and pulmonary function than those in the control group. Adverse reactions to tetrandrine, including facial pigmentation and liver function abnormalities, were mild.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Tetrandrine significantly mitigated HRCT-detected disease progression and lung function decline in patients with artificial stone-associated silicosis, particularly after prolonged treatment. These findings suggest that tetrandrine may serve as a viable therapeutic option for managing artificial stone-associated silicosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12890-025-03821-8","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T13:44:04Z","timestamp":1752932644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tetrandrine slows disease progression on high-resolution computed tomography and lung function decline in artificial stone-associated silicosis: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Shaowei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zidan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqin","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"3821_CR1","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(12)60235-9","volume":"379","author":"CC Leung","year":"2012","unstructured":"Leung CC, Yu ITS, Chen W. Silicosis. Lancet. 2012;379:2008\u201318. https:\/\/doi.org\/10.1016\/S0140-6736(12)60235-9.","journal-title":"Lancet."},{"key":"3821_CR2","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.chest.2020.03.026","volume":"158","author":"A Le\u00f3n-Jim\u00e9nez","year":"2020","unstructured":"Le\u00f3n-Jim\u00e9nez A, Hidalgo-Molina A, Conde-S\u00e1nchez M\u00c1, P\u00e9rez-Alonso A, Morales-Morales JM, Garc\u00eda-G\u00e1mez EM, et al. Artificial stone silicosis: Rapid progression following exposure cessation. Chest. 2020;158:1060\u20138. https:\/\/doi.org\/10.1016\/j.chest.2020.03.026.","journal-title":"Chest."},{"key":"3821_CR3","unstructured":"National Institute for Occupational Safety and Health. Health effects of occupational exposure to respirable crystalline silica. 2002. https:\/\/www.cdc.gov\/niosh\/docs\/2002-129\/default.html. Accessed 20 Mar 2025."},{"key":"3821_CR4","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1111\/all.14202","volume":"75","author":"RF Hoy","year":"2020","unstructured":"Hoy RF, Chambers DC. Silica-related diseases in the modern world. Allergy. 2020;75:2805\u201317. https:\/\/doi.org\/10.1111\/all.14202.","journal-title":"Allergy."},{"key":"3821_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.31083\/j.fbl2805096","volume":"28","author":"CM Handra","year":"2023","unstructured":"Handra CM, Gurzu IL, Chirila M, Ghita I. Silicosis: New challenges from an old inflammatory and fibrotic disease. Front Biosci (Landmark Ed). 2023;28:96. https:\/\/doi.org\/10.31083\/j.fbl2805096.","journal-title":"Front Biosci (Landmark Ed)."},{"key":"3821_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/MCP.0000000000001020","volume":"30","author":"H Barnes","year":"2024","unstructured":"Barnes H, Lam M, Tate MD, Hoy R. Toward targeted treatments for silicosis. Curr Opin Pulm Med. 2024;30:185\u201394. https:\/\/doi.org\/10.1097\/MCP.0000000000001020.","journal-title":"Curr Opin Pulm Med."},{"key":"3821_CR7","doi-asserted-by":"publisher","first-page":"00086","DOI":"10.1183\/23120541.00086-2015","volume":"2","author":"N Ophir","year":"2016","unstructured":"Ophir N, Shai AB, Alkalay Y, Israeli S, Korenstein R, Kramer MR, et al. Artificial stone dust-induced functional and inflammatory abnormalities in exposed workers monitored quantitatively by biometrics. ERJ Open Res. 2016;2:00086\u20132015. https:\/\/doi.org\/10.1183\/23120541.00086-2015.","journal-title":"ERJ Open Res."},{"key":"3821_CR8","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/ijerph16040568","volume":"16","author":"V Leso","year":"2019","unstructured":"Leso V, Fontana L, Romano R, Gervetti P, Iavicoli I. Artificial stone associated silicosis: a systematic review. Int J Environ Res Public Health. 2019;16:568. https:\/\/doi.org\/10.3390\/ijerph16040568.","journal-title":"Int J Environ Res Public Health."},{"key":"3821_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/19338244.2022.2105287","volume":"78","author":"WK Mandler","year":"2023","unstructured":"Mandler WK, Qi C, Qian Y. Hazardous dusts from the fabrication of countertop: A review. Arch Environ Occup Health. 2023;78:118\u201326. https:\/\/doi.org\/10.1080\/19338244.2022.2105287.","journal-title":"Arch Environ Occup Health."},{"key":"3821_CR10","doi-asserted-by":"publisher","first-page":"5625","DOI":"10.3390\/ijerph18115625","volume":"18","author":"M Requena-Mullor","year":"2021","unstructured":"Requena-Mullor M, Alarc\u00f3n-Rodr\u00edguez R, Parr\u00f3n-Carre\u00f1o T, Mart\u00ednez-L\u00f3pez JJ, Lozano-Paniagua D, Hern\u00e1ndez AF. Association between crystalline silica dust exposure and silicosis development in artificial stone workers. Int J Environ Res Public Health. 2021;18:5625. https:\/\/doi.org\/10.3390\/ijerph18115625.","journal-title":"Int J Environ Res Public Health."},{"key":"3821_CR11","doi-asserted-by":"publisher","first-page":"118773","DOI":"10.1016\/j.envres.2024.118773","volume":"251","author":"D Mart\u00ednez-Gonz\u00e1lez","year":"2024","unstructured":"Mart\u00ednez-Gonz\u00e1lez D, Carballo-Men\u00e9ndez M, Guzm\u00e1n-Taveras R, Quero-Mart\u00ednez A, Fern\u00e1ndez-Tena A. Evaluating silicosis risk: assessing dust constitution and influence of water as a primary prevention measure in cutting and polishing of silica agglomerates, granite and marble. Environ Res. 2024;251:118773. https:\/\/doi.org\/10.1016\/j.envres.2024.118773.","journal-title":"Environ Res."},{"key":"3821_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12940-024-01067-1","volume":"23","author":"CH Chen","year":"2024","unstructured":"Chen CH, Tsai PJ, Chang WW, Chen CY, Chen CY, Yates D, et al. Dose-response relationship between lung function and chest imaging response to silica exposures in artificial stone manufacturing workers. Environ Health. 2024;23:25. https:\/\/doi.org\/10.1186\/s12940-024-01067-1.","journal-title":"Environ Health."},{"key":"3821_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/resp.13744","volume":"25","author":"N Wu","year":"2020","unstructured":"Wu N, Xue C, Yu S, Ye Q. Artificial stone-associated silicosis in China: a prospective comparison with natural stone-associated silicosis. Respirology. 2020;25:518\u201324. https:\/\/doi.org\/10.1111\/resp.13744.","journal-title":"Respirology."},{"key":"3821_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.joim.2021.01.001","volume":"19","author":"EWC Chan","year":"2021","unstructured":"Chan EWC, Wong SK, Chan HT. An overview on the chemistry, pharmacology and anticancer properties of tetrandrine and fangchinoline (alkaloids) from Stephania tetrandra roots. J Integr Med. 2021;19:311\u20136. https:\/\/doi.org\/10.1016\/j.joim.2021.01.001.","journal-title":"J Integr Med."},{"key":"3821_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.phytochem.2016.02.005","volume":"125","author":"N Bhagya","year":"2016","unstructured":"Bhagya N, Chandrashekar KR. Tetrandrine\u2013A molecule of wide bioactivity. Phytochemistry. 2016;125:5\u201313. https:\/\/doi.org\/10.1016\/j.phytochem.2016.02.005.","journal-title":"Phytochemistry."},{"key":"3821_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/toxics11090765","volume":"11","author":"Y Wang","year":"2023","unstructured":"Wang Y, Cheng B, Lin YJ, Wang R, Xuan J, Xu HM. Preliminary study on the effect and molecular mechanism of tetrandrine in alleviating pulmonary inflammation and fibrosis induced by silicon dioxide. Toxics. 2023;11:765. https:\/\/doi.org\/10.3390\/toxics11090765.","journal-title":"Toxics."},{"key":"3821_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/1754-9485.13015","volume":"64","author":"CM Jones","year":"2020","unstructured":"Jones CM, Pasricha SS, Heinze SB, MacDonald S. Silicosis in artificial stone workers: Spectrum of radiological high-resolution CT chest findings. J Med Imaging Radiat Oncol. 2020;64:241\u20139. https:\/\/doi.org\/10.1111\/1754-9485.13015.","journal-title":"J Med Imaging Radiat Oncol."},{"key":"3821_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/oemed-2017-104428","volume":"75","author":"RF Hoy","year":"2018","unstructured":"Hoy RF, Baird T, Hammerschlag G, Hart D, Johnson AR, King P, et al. Artificial stone-associated silicosis: A rapidly emerging occupational lung disease. Occup Environ Med. 2018;75:3\u20135. https:\/\/doi.org\/10.1136\/oemed-2017-104428.","journal-title":"Occup Environ Med."},{"key":"3821_CR19","doi-asserted-by":"publisher","first-page":"1516200","DOI":"10.3389\/fphar.2025.1516200","volume":"16","author":"B Yang","year":"2025","unstructured":"Yang B, Liu X, Peng C, Meng X, Jia Q. Silicosis: From pathogenesis to therapeutics. Front Pharmacol. 2025;16:1516200. https:\/\/doi.org\/10.3389\/fphar.2025.1516200.","journal-title":"Front Pharmacol."},{"key":"3821_CR20","doi-asserted-by":"publisher","first-page":"832052","DOI":"10.3389\/fmed.2022.832052","volume":"9","author":"H Quan","year":"2022","unstructured":"Quan H, Wu W, Yang G, Wu Y, Yang W, Min C, et al. Risk factors of silicosis progression: a retrospective cohort study in China. Front Med (Lausanne). 2022;9:832052. https:\/\/doi.org\/10.3389\/fmed.2022.832052.","journal-title":"Front Med (Lausanne)."},{"key":"3821_CR21","first-page":"92","volume":"6","author":"HX Jiang","year":"1983","unstructured":"Jiang HX. Preliminary study of the mechanism of silicosis therapy by tetrandrine. Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi. 1983;6:92\u20134.\u00a0PMID: 6628134.","journal-title":"Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi."},{"key":"3821_CR22","first-page":"243","volume":"5","author":"QL Li","year":"1982","unstructured":"Li QL. Autopsy and histochemical analysis: Report of a case of silicosis treated with tetrandrine. Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi. 1982;5:243\u20134.\u00a0PMID: 7172937.","journal-title":"Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi."},{"key":"3821_CR23","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s41401-021-00693-6","volume":"43","author":"MY Song","year":"2022","unstructured":"Song MY, Wang JX, Sun YL, Han ZF, Zhou YT, Liu Y, et al. Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages. Acta Pharmacol Sin. 2022;43:1274\u201384. https:\/\/doi.org\/10.1038\/s41401-021-00693-6.","journal-title":"Acta Pharmacol Sin."},{"key":"3821_CR24","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10753-023-01964-6","volume":"47","author":"R Ma","year":"2024","unstructured":"Ma R, Huang X, Sun D, Wang J, Xue C, Ye Q. Tetrandrine alleviates silica-induced pulmonary fibrosis through PI3K\/AKT pathway: Network pharmacology investigation and experimental validation. Inflammation. 2024;47:1109\u201326. https:\/\/doi.org\/10.1007\/s10753-023-01964-6.","journal-title":"Inflammation."},{"key":"3821_CR25","doi-asserted-by":"publisher","first-page":"1107967","DOI":"10.3389\/fmed.2023.1107967","volume":"10","author":"WH Wu","year":"2023","unstructured":"Wu WH, Feng YH, Min CY, Zhou SW, Chen ZD, Huang LM, et al. Clinical efficacy of tetrandrine in artificial stone-associated silicosis: A retrospective cohort study. Front Med (Lausanne). 2023;10:1107967. https:\/\/doi.org\/10.3389\/fmed.2023.1107967.","journal-title":"Front Med (Lausanne)."},{"key":"3821_CR26","first-page":"130","volume":"14","author":"DH Li","year":"1996","unstructured":"Li DH. Task group of clinical evaluation on therapeutic effects of drug treatment for silicosis. Clinical trial and evaluation of treatment for silicosis. Chin J Ind Hyg Occup Dis. 1996;14:130\u20134.","journal-title":"Chin J Ind Hyg Occup Dis."},{"key":"3821_CR27","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.2214\/AJR.07.2402","volume":"189","author":"E Marchiori","year":"2007","unstructured":"Marchiori E, Souza CA, Barbassa TG, Escuissato DL, Gasparetto EL, Souza AS Jr. Silicoproteinosis: high-resolution CT findings in 13 patients. AJR Am J Roentgenol. 2007;189:1402\u20136. https:\/\/doi.org\/10.2214\/AJR.07.2402.","journal-title":"AJR Am J Roentgenol."},{"key":"3821_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1148\/rg.261055070","volume":"26","author":"S Chong","year":"2006","unstructured":"Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS. Pneumoconiosis: comparison of imaging and pathologic findings. RadioGraphics. 2006;26:59\u201377. https:\/\/doi.org\/10.1148\/rg.261055070.","journal-title":"RadioGraphics."}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03821-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03821-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03821-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T13:44:06Z","timestamp":1752932646000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03821-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3821"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03821-8","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of Shanghai Pulmonary Hospital and the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of Shanghai Pulmonary Hospital (Approval Number: K22-313). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}